{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:43:30Z","timestamp":1785894210297,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,2]]},"DOI":"10.7759\/cureus.14808","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T01:59:05Z","timestamp":1620007145000},"source":"Crossref","is-referenced-by-count":2,"title":["Secondary Gamma-Delta T-Cell Lymphoma Not Otherwise Specified (NOS) From Chronic Immunosuppression"],"prefix":"10.7759","author":[{"given":"Madeleine E","family":"Turcotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar H","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chaffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam H","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12439","article-title":"Gamma-delta t-cell lymphomas","volume":"94","author":"Foppoli M","year":"2015","unstructured":"Foppoli M, Ferreri AJ. Gamma-delta t-cell lymphomas. Eur J Haematol. 2015, 94:206-18. 10.1111\/ejh.12439","journal-title":"Eur J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.85542","article-title":"Gamma-delta T-cell lymphoma: an overview","author":"Ramachandran P","year":"2019","unstructured":"Ramachandran P, Aggarwal A, Wang JC. Gamma-delta T-cell lymphoma: an overview. T-Cell Lymphoma. Piccaluga PP (ed): InTechOpen, London, United Kingdom; 2019. 55-75. 10.5772\/intechopen.85542"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1312-5","article-title":"Gamma-delta (\u03b3\u03b4) T-cell lymphoma - another case unclassifiable by World Health Organization classification: a case report","volume":"11","author":"Sindhu H","year":"2017","unstructured":"Sindhu H, Chen R, Chen H, Wong J, Chaudhry R, Xu Y, Wang JC. Gamma-delta (\u03b3\u03b4) T-cell lymphoma - another case unclassifiable by World Health Organization classification: a case report. J Med Case Rep. 2017, 11:163. 10.1186\/s13256-017-1312-5","journal-title":"J Med Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0079-RS","article-title":"Hepatosplenic T-cell lymphoma: a clinicopathologic review with an emphasis on diagnostic differentiation from other t-cell\/natural killer-cell neoplasms","volume":"139","author":"Shi Y","year":"2015","unstructured":"Shi Y, Wang E. Hepatosplenic T-cell lymphoma: a clinicopathologic review with an emphasis on diagnostic differentiation from other t-cell\/natural killer-cell neoplasms. Arch Pathol Lab Med. 2015, 139:1173-80. 10.5858\/arpa.2014-0079-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and \u03b3\u03b4 T-cell large granular lymphocytic leukemia. A clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe M","year":"2017","unstructured":"Yabe M, Medeiros LJ, Wang SA, et al.. Distinguishing between hepatosplenic T-cell lymphoma and \u03b3\u03b4 T-cell large granular lymphocytic leukemia. A clinicopathologic, immunophenotypic, and molecular analysis. Am J Surg Pathol. 2017, 41:82-93. 10.1097\/PAS.0000000000000743","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart J","year":"2012","unstructured":"Guitart J, Weisenburger DD, Subtil A, et al.. Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol. 2012, 36:1656-65. 10.1097\/PAS.0b013e31826a5038","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2258-7","article-title":"The presenting manifestations of subcutaneous panniculitis-like T-cell lymphoma and T-cell lymphoma and cutaneous \u03b3\u03b4 T-cell lymphoma may mimic those of rheumatic diseases: a report of 11 cases","volume":"32","author":"Yi L","year":"2013","unstructured":"Yi L, Qun S, Wenjie Z, Wen Z, Jian L, Yan Z, Fengchun Z. The presenting manifestations of subcutaneous panniculitis-like T-cell lymphoma and T-cell lymphoma and cutaneous \u03b3\u03b4 T-cell lymphoma may mimic those of rheumatic diseases: a report of 11 cases. Clin Rheumatol. 2013, 32:1169-75. 10.1007\/s10067-013-2258-7","journal-title":"Clin Rheumatol"},{"key":"ref9","article-title":"Nonhepatosplenic \u03b3\u03b4 T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization","volume":"91","author":"Arnulf BB","year":"1998","unstructured":"Arnulf BB, Copie-Bergman C, Lavergne-Slove A, et al.. Nonhepatosplenic \u03b3\u03b4 T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998, 91:1723-1731.","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199706000-00015","article-title":"A nodal gamma\/delta T-cell lymphoma with an association of Epstein-Barr virus","volume":"21","author":"Kagami Y","year":"1997","unstructured":"Kagami Y, Nakamura S, Suzuki R, et al.. A nodal gamma\/delta T-cell lymphoma with an association of Epstein-Barr virus. Am J Surg Pathol. 1997, 21:729-36. 10.1097\/00000478-199706000-00015","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf293","article-title":"Gamma delta T-cell neoplasms: a clinicopathological study of 11 cases","volume":"13","author":"Saito T","year":"2002","unstructured":"Saito T, Matsuno Y, Tanosaki R, Watanabe T, Kobayashi Y, Tobinai K. Gamma delta T-cell neoplasms: a clinicopathological study of 11 cases. Ann Oncol. 2002, 13:1792-8. 10.1093\/annonc\/mdf293","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90353-6","article-title":"Peripheral CD4+ CD8- \u03b3\u03b4 T-cell lymphoma: a case report with multiparameter analysis","volume":"27","author":"Ichinohasama R","year":"1996","unstructured":"Ichinohasama R, Miura I, Takahashi T, et al.. Peripheral CD4+ CD8- \u03b3\u03b4 T-cell lymphoma: a case report with multiparameter analysis. Hum Pathol. 1996, 27:1370-7. 10.1016\/S0046-8177(96)90353-6","journal-title":"Hum Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318222dfcd","article-title":"Type II enteropathy-associated T-cell lymphoma. A distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression","volume":"35","author":"Chan JK","year":"2011","unstructured":"Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, Lui YH, Chan WK. Type II enteropathy-associated T-cell lymphoma. A distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression. Am J Surg Pathol. 2011, 35:1557-69. 10.1097\/PAS.0b013e318222dfcd","journal-title":"Am J Surg Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.17.3742","article-title":"Unusual hematologic malignancies. Case 3. CNS involvement in CD56-positive intestinal gamma\/delta T-cell lymphoma","volume":"20","author":"Chim CS","year":"2002","unstructured":"Chim CS, Lam CC, Nicholls JM, Ooi GC, Kwong YL. Unusual hematologic malignancies. Case 3. CNS involvement in CD56-positive intestinal gamma\/delta T-cell lymphoma. J Clin Oncol. 2002, 20:3742-4. 10.1200\/JCO.2002.20.17.3742","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-219946","article-title":"Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss","volume":"2017","author":"Jones N","year":"2017","unstructured":"Jones N, Gibb A, Irion L, Coupland S. Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss. BMJ Case Rep. 2017, 2017:bcr-2017-219946. 10.1136\/bcr-2017-219946","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz S","year":"2019","unstructured":"Horwitz S, O'Connor OA, Pro B, et al.. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019, 393:229-40. 10.1016\/S0140-6736(18)32984-2","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.11.013","article-title":"A single-center experience with brentuximab vedotin in gamma delta t-cell lymphoma","volume":"16","author":"Talpur R","year":"2016","unstructured":"Talpur R, Chockalingam R, Wang C, Tetzlaff MT, Duvic M. A single-center experience with brentuximab vedotin in gamma delta t-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2016, 16:e15-9. 10.1016\/j.clml.2015.11.013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.1512.1512","article-title":"Outcome of patients with gamma delta T cell lymphomas: analysis of 1429 cases registered in the prospective t-cell project","volume":"130","author":"Foss FM","year":"2017","unstructured":"Foss FM, Horwitz SM, Bellei M, et al.. Outcome of patients with gamma delta T cell lymphomas: analysis of 1429 cases registered in the prospective t-cell project. Blood. 2017, 130:1512. 10.1182\/blood.V130.Suppl_1.1512.1512","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55571-secondary-gamma-delta-t-cell-lymphoma-not-otherwise-specified-nos-from-chronic-immunosuppression","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:39Z","timestamp":1707507099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55571-secondary-gamma-delta-t-cell-lymphoma-not-otherwise-specified-nos-from-chronic-immunosuppression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,2]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.14808","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,2]]}}}